AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 SEP 3 - (NewsRx.com & NewsRx.net) -- A vaccine administered through the nasal passages may increase protection against pneumococcal disease compared to the current vaccine, say researchers from Albany Medical College in New York and the University of Alabama at Birmingham.
Streptococcus pneumoniae, a common cause of bacterial pneumonia, generally enters the body through the nose. While the current intramuscular immunizations are effective in fighting the disease, their ability to protect against bacterial carriage in the nasal passages is only 50-60%.
In the study, published in Infection and Immunity, mice were immunized intranasally, treated with interleukin-12 to enhance mucosal immune response and then challenged with varying strains of S. pneumoniae. The researchers found a 75% survival rate of vaccinated mice as ...
Source: HighBeam Research, Nasal vaccine may increase protection.